Effects of Directional Subthalamic Deep Brain Stimulation on Gait and Balance in Parkinson's Disease Patients

STATUS

Recruiting
participants needed

10
sponsor

University Hospital, Rouen

Send

Updated on 19 February 2024

See if I qualify

estrogen

brain stimulation

tubal ligation

parkinson's disease

dopa

Summary

Show definitions

Deep brain stimulation of the NST is effective for cardinal motor signs in patients with idiopathic Parkinson's disease (IPD), its effects on gait disturbances, especially freezing of gait-FOG, and falls are variable from one patient to another, in part depending on the location of the NST-stimulating contact. The ability to change the shape of the current field, and thus the volume of activated tissue, with a directional stimulation electrode is a new treatment option for NSC SCP patients with Parkinson's disease. In this pilot research program, the main objective is to determine the impact of directional DBS on gait and balance issues for PD patients implanted in the STN, using previously described anatomical and functional data for gait disturbances to guide directional programming. Ten patients with Patients with severe form of Parkinson's disease eligible to deep brain stimulation of the subthalamic nucleus, will be included in two French sites.

Details

Condition	Parkinson's Disease, Parkinson's Disease
Age	18years - 70years
Treatment	Directional and single ring STN-DBS on gait
Clinical Study Identifier	NCT04223427
Sponsor	University Hospital, Rouen
Last Modified on	19 February 2024

How understandable was the trial content above?

Hard to understand

Easy to understand

Eligibility		Yes	No	Not Sure
Inclusion Criteria
	Age between 18 and 70 years
	Diagnosis of Parkinson's Disease; as defined by the United Kingdom Parkinson's Disease Society Brain Bank (UKPDSBB) criteria
	Patients eligible for subthalamic bilateral deep brain stimulation (STN-DBS) according to local inclusion criteria
	Freezing of gait in the OFF-dopa condition with item 2.13 of the MDS-UPDRS > 0 in usual life
	Patient having read and understood the information letter and signed the Informed Consent Form
	Patient affiliated with, or beneficiary of a social security category
	Stability of others medical disorders or that do not interfere with the research protocol
	Woman of childbearing potential with effective contraception according to WHO definition (estrogen-progestin or intra-uterine device or tubal ligation) since at least 3 months (negative urinary pregnancy test at inclusion)
Exclusion Criteria
	Actual and severe psychiatric pathology or other neurological disorder
	Dementia (MMS <24/30)
	Contraindication to research MRI (without contrast product) such as claustrophobia, metallic splinters in the eyes, ferromagnetic foreign bodies close to nerve structures, cardiac, ORL and neurological devices not MRI compatible, wearing of osteosynthseis equipment prior to 1980, metal prostheses, bypass valves ventriculoperitoneal neurosurgery, tattoos containing iron particles
	Contraindication to surgery: hemostasis trouble, anticoagulants or antiagregants treatment, ongoing infection
	Hypersensitivity to contrasts agents
	Persons under guardianship, tutorship or any other administrative or judicial measure of deprivation of rights and liberty
	Subject at the time of exclusion from other biomedical research or participating in any other biomedical research or therapeutic trial
	Pregnant or parturient or lactating woman or lack of proven and effective contraception according to WHO definition (estrogen-progestin or intra-uterine device or tubal ligation) (for women of childbearing age)

How to participate?

Step 1 Connect with a study center

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Other language

I am at least 18 years old.

By sending a message, I agree to share my information with the study team for the selected site and consent to receive emails and text messages for trial updates, notifications, and related communication. TrialX values your privacy; your information will be handled in accordance with our Privacy Policy

Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Effects of Directional Subthalamic Deep Brain Stimulation on Gait and Balance in Parkinson's Disease Patients